Cargando…

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma

Liver hepatocellular carcinoma (LIHC) is one of the most lethal tumors worldwide, and while its detailed mechanism of occurrence remains unclear, an early diagnosis of LIHC could significantly improve the 5-years survival of LIHC patients. It is therefore imperative to explore novel molecular marker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xiaoyan, Wen, Junye, Bao, Lei, Gao, Fei, Li, You, He, Dongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793833/ https://www.ncbi.nlm.nih.gov/pubmed/35095994 http://dx.doi.org/10.3389/fgene.2021.681809

Ejemplares similares

Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data
por: Kaur, Harpreet, et al.
Publicado: (2020)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2022)

Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses
por: Al-Harazi, Olfat, et al.
Publicado: (2021)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis
por: Niu, Xiaoji, et al.
Publicado: (2022)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Identification of Potential Diagnostic and Prognostic Biomarkers for Colorectal Cancer Based on GEO and TCGA Databases
por: Wang, Zhenjiang, et al.
Publicado: (2021)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration
por: Jia, Boquan, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
por: Pu, Zhangya, et al.
Publicado: (2021)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

Identification of Multigene Biomarker for Shrimp White Feces Syndrome by Full-Length Transcriptome Sequencing
por: Zeng, Shenzheng, et al.
Publicado: (2020)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes
por: Sun, Ruge, et al.
Publicado: (2022)

DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma
por: Zhou, Chao, et al.
Publicado: (2019)

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
por: Ma, Keqiang, et al.
Publicado: (2023)

Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma
por: Chen, Shanshan, et al.
Publicado: (2022)

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma
por: Rao, Jiawei, et al.
Publicado: (2020)

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers
por: Wang, Hengzhen, et al.
Publicado: (2021)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022)

Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma
por: Yang, Xiawei, et al.
Publicado: (2022)

Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma
por: Liu, Ruifei, et al.
Publicado: (2022)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling
por: Zeng, Bin, et al.
Publicado: (2021)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)

RPP30 is a novel diagnostic and prognostic biomarker for gastric cancer
por: Kan, Ying, et al.
Publicado: (2022)

Identification and Validation of a Five-Gene Diagnostic Signature for Preeclampsia
por: Liu, Yu, et al.
Publicado: (2022)

Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
por: Liu, Shanshan, et al.
Publicado: (2021)

Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma
por: Chen, Xingte, et al.
Publicado: (2021)

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022)

MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation
por: Yip, Shun H., et al.
Publicado: (2019)

Identification and Validation of Potential Biomarkers and Their Functions in Acute Kidney Injury
por: Chen, Jianwen, et al.
Publicado: (2020)

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv66ir9kpj2accga86shfh1opq